Archive

Medical aid tax credits may be withdrawn from 2026. Analysis warns of medical aid membership losses and rising public-sector pressure.

Gauteng health turmoil as MEC Nomantu Nkomo-Ralehoko backs Lesiba Malotana despite SIU flags and fresh questions over hospital beds.

Sizwe Hosmed Curatorship is under scrutiny as curator Lebogang Mpakati defends private legal matters and outlines steps to restore solvency.

Eli Lilly has forecast 2026 profit and revenue above Wall Street expectations, reinforcing how fast the obesity market is reshaping Big Pharma growth plans. The recent Eli Lilly 2026 Guidance reflects the company’s confidence in strong future performance. The company also beat estimates for fourth-quarter earnings, helped by strong demand for its injectable weight-loss and […]

South Africa’s first consignment of lenacapavir, a six-monthly HIV prevention injection for high-risk HIV-negative people, will cover fewer than a quarter of the target population. Deliveries are underway and will continue through April. Rollout will begin immediately after delivery, with an initial two-year implementation plan.

As National Pregnancy Week runs from 3-7 February, the South African Society of Psychiatrists (Sasop) is calling on healthcare providers and expectant mothers to treat perinatal mental health symptoms in pregnancy as urgent medical issues. The society says between 16% and 50% of women in South Africa experience depression or anxiety during pregnancy. It adds […]

Discover how healthcare investment drives growth, linking public health to stronger GDP performance in emerging markets.

Barrs Pharmaceuticals has exited business rescue after agreeing to sell a controlling stake to Hetero. The deal signals a reset for a local manufacturer that has faced both operational disruption and regulatory pressure.

The US WHO Withdrawal became final in January 2026, raising risks for flu surveillance, outbreak response, and WHO funding as job cuts loom.

South Africa launches the HIV vaccine trial, BRILLIANT 01, testing a new vaccine cocktail designed to prime broadly neutralising antibodies.

Get insights into the Bonitas Tender Dispute as Bonitas reacts to Medscheme’s challenge over service provider appointments.